1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Morocco Pharmaceuticals and Healthcare Report Q2 2016

Morocco Pharmaceuticals and Healthcare Report Q2 2016

  • March 2016
  • -
  • Business Monitor International
  • -
  • 101 pages

Includes 3 FREE quarterly updates

BMI View: We hold an optimistic outlook for the Moroccan pharmaceutical market despite the economicslowdown over 2016. We expect the government's increasing efforts to improve healthcare coveragecoupled with the country's growing non-communicable disease burden will drive the demand for medicinesin long-term. A major downside risk to our forecast is the uncertainty surrounding drug prices as a result ofprice cuts and increased taxation on medicines in recent years, which will negatively impact theattractiveness of the market to multinational drugmakers.

Headline Expenditure Projections

- Pharmaceuticals: MAD13.39bn (USD1.40bn) in 2015 to MAD14.34bn (USD1.46bn) in 2016; +7.1% inlocal currency terms and +4.0% in US dollar terms. Forecast inline with last quarter.

- Healthcare: MAD59.15bn (USD6.19bn) in 2015 to MAD62.83bn (USD6.38bn) in 2016; +6.2% in localcurrency terms and +3.1% in US dollar terms. Forecast revised downwards from last quarter.

Table Of Contents

Morocco Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Morocco 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Morocco 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Morocco 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Morocco 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Morocco 2012-2020) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Morocco 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Morocco 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Morocco 2012-2020) 26
OTC Drug Market Forecast 27
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Morocco 2012-2020) 29
Pharmaceutical Trade Forecast 30
Table: Pharmaceutical Trade Data And Forecasts (Morocco 2014-2020) 33
Table: Pharmaceutical Trade Data And Forecasts local currency (Morocco 2014-2020) 33
Pharmaceuticals and Healthcare Risk/Reward Index 34
Middle East and Africa Risk/Reward Index - Q2 2016 34
Morocco Risk/ Reward Index 41
Rewards 41
Risks 42
Regulatory Review 44
Intellectual Property Regime 45
Pricing Regime 45
Reimbursement Regime 48
Market Overview 51
Epidemiology 51
Healthcare Sector 54
Table: Healthcare Resources (Morocco 2010-2015) 58
Table: Healthcare Personnel (Morocco 2010-2015) 59
Table: Healthcare Activity (Morocco 2010-2015) 59
Healthcare Insurance 59
Recent Health Insurance Developments 61
Research and Development 64
Clinical Trials 65
Competitive Landscape 66
Pharmaceutical Industry 66
Table: Morocco's Select Pharmaceutical Industry Indicators 66
Table: Members Of MIS, 2011 67
Table: Members Of AMIP, 2011 68
Domestic Pharmaceutical sector 68
Foreign Pharmaceutical Companies 69
Table: Multinational Market Activity 72
Pharmaceutical Wholesale 72
Pharmaceutical Retail 73
Company Profile 75
GlaxoSmithKline 75
Laprophan 77
Pfizer 80
Sanofi 83
Sothema 87
Demographic Forecast 90
Demographic Outlook 90
Table: Population Headline Indicators (Morocco 1990-2025) 91
Table: Key Population Ratios (Morocco 1990-2025) 91
Table: Urban/Rural Population and Life Expectancy (Morocco 1990-2025) 92
Table: Population By Age Group (Morocco 1990-2025) 92
Table: Population By Age Group % (Morocco 1990-2025) 93
Glossary 95
Methodology 97
Pharmaceutical Expenditure Forecast Model 97
Healthcare Expenditure Forecast Model 97
Notes On Methodology 98
Risk/Reward Index Methodology 99
Index Overview 100
Table: Pharmaceutical Risk/Reward Index Indicators 100
Indicator Weightings 101

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.